Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Marathon Digital Holdings Inc (MARA) Price & Performance

Amphastar Pharmaceuticals IncTrade
Marathon Digital Holdings IncTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Marathon Digital Holdings Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Marathon Digital Holdings Inc trades at $9.83 (market cap $3.69B). The key difference: Marathon Digital Holdings Inc is far larger — about 4.3× Amphastar Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.

AMPHMARA
Market Cap
$863.95M$3.69B
Sector
HealthTechnology
52-Week High
$30.81$22.84
52-Week Low
$16.87$6.73
Enterprise Value
$1.26B$5.74B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amphastar Pharmaceuticals Inc

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Marathon Digital Holdings Inc

MARA Holdings trades at $10.09, down 5.26% amid a bearish technical signal and recent earnings misses. The stock faces fundamental pressure with a net income margin of -429.71% for 2026 and negative cash flow from operations. Despite this, analyst consensus remains optimistic with a $16.08 price target, and the company is pivoting its power infrastructure toward AI compute to complement Bitcoin mining.

The outlook is mixed; the high analyst buy rating and strategic pivot offer potential upside, but persistent losses, negative cash flow, and Bitcoin market volatility pose significant risks. Investor sentiment is cautious following Q2 2026 results, with the stock trading well below its 52-week high, highlighting both opportunity and substantial downside exposure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Marathon Digital Holdings Inc

Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.

Read more on MARA